Registration Now Open for BOS Events 2024!

Bio2Business Ltd is delighted to open registration for BOS Events 2024 which includes: BOS Basel 2024, which will take place on the 19th and 20th of June at Congress Centre Basel; and BOS Manchester 2024, which will take place on the 26th and 27th of November at Manchester Central.

The focus of these events is partnerships in R&D outsourcing with the primary scope being development-stage CMC outsourcing of Small Molecules, Biologics and New Therapeutic Entities.

We continue to evaluate the opportunity for virtual events during 2024. We look forward to welcoming you and your colleagues to BOS Events 2024! Please contact the Bio2Business team for further details.

Featured Company (BOS Manchester 2023)

WuXi STA
WuXi STA, a subsidiary of WuXi AppTec, is a leading pharmaceutical development and manufacturing capability and technology platform company serving the life sciences industry, with global operations across North America, Europe and Asia. As a premier Contract Development and Manufacturing Organization...
View profile

Featured Speaker (BOS Basel 2023)

Biotherapeutics Development and Production at Outsourcing Partners – How to Best Manage the Partnerships

Dr Ulrich Rümenapp, Senior Program Lead, Bayer AG

ABSTRACT: Many smaller and big pharma/ biotech companies employ outsourcing of the CMC development and manufacturing of their biologics to CDMOs for various strategic reasons. Thus, outsourcing partnerships are of crucial importance. For their clinical and/ or commercial manufacture, the companies must decide between building internal capabilities or outsourcing. Especially for biologics, this needs thorough evaluation and decision-making due to the technical complexity. This presentation will review the pros and cons as well as risks and mitigations of outsourcing CMC development and bio-manufacturing.... Click here to Read More